Hims Hers Health Inc (HIMS)

Featured in High-Beta Stocks

Hims & Hers Health, Inc. is a healthcare company listed on the NYSE under the ticker HIMS. It operates a consumer-focused health and wellness platform that connects patients with licensed healthcare professionals in the United States and several international markets, including the United Kingdom, Canada, Germany, the Republic of Ireland, France, and Spain. Through its websites and mobile app, the company provides prescription and non-prescription products, along with related services such as medical consultations, post-consultation support, and laboratory testing. Its branded offerings cover areas such as general wellness, skincare, sexual health, hair care, hormone health, weight loss, dermatology, and mental health. The company is based in San Francisco, California.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-HIMS
$24.29
-27.0% Downside
Overvalued
$28.42
-14.6% Downside
Fair
Good
0.0%
August 10, 2026
-583.6x
17.3x
3.3x
7.569 B
8.105 B
13.0%
91.0%
4.1
-602.3%
Valuation • Fair Value

Hims Hers Health Inc (NYSE-HIMS) Fair Value by Valuation Model

Compare the primary fair value estimate for Hims Hers Health Inc (NYSE-HIMS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$24.29

Estimated downside of 27.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$23.43

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$25.15

Comparable-company valuation reference.

Analyst Price Target

$28.42

Analysts imply downside of 14.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Hims Hers Health Inc (NYSE-HIMS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Hims Hers Health Inc (NYSE-HIMS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.37 B

Current operating scale indicator.

Revenue Forecast

3.021 B

Forward revenue estimate.

EBITDA

83.416 M

Current operating profitability reference.

EBITDA Forecast

295.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Hims Hers Health Inc (NYSE-HIMS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Hims Hers Health Inc (NYSE-HIMS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

11.00

Higher caution zone on this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

-602.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Hims Hers Health Inc (NYSE-HIMS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Hims Hers Health Inc (NYSE-HIMS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 10, 2026

Days to Earnings

20

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Hims Hers Health Inc (NYSE-HIMS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Hims Hers Health Inc (NYSE-HIMS) Stock Forecast & Technical Outlook

Review Hims Hers Health Inc (NYSE-HIMS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Hims Hers Health Inc (NYSE-HIMS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Hims Hers Health Inc (NYSE-HIMS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Hims Hers Health Inc (NYSE-HIMS) has a Hold consensus, with 1 buy, 11 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 11
Sell 0
FAQ Fast Investor Answers

Hims Hers Health Inc (NYSE-HIMS) Stock FAQ

Quick answers about Hims Hers Health Inc (NYSE-HIMS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$24.29
Estimated downside 27.0%
Valuation Rating
Overvalued
Estimated downside of 27.0%
Analyst Target
$28.42
Implied downside 14.6%
Financial Health
Good
Current financial-health read

The current fair value estimate for Hims Hers Health Inc (NYSE-HIMS) is $24.29. This implies an estimated downside of 27.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 27.0% versus the current market price.

The available analyst price target for Hims Hers Health Inc (NYSE-HIMS) is $28.42. The analyst target implies estimated downside of 14.6%.

The current financial health read for Hims Hers Health Inc (NYSE-HIMS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Hims Hers Health Inc (NYSE-HIMS) is August 10, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Hims Hers Health Inc (NYSE-HIMS) is -583.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Hims Hers Health Inc is 7.569 B.

The current enterprise value listed for Hims Hers Health Inc is 8.105 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Hims Hers Health Inc is NYSE-HIMS, and the stock is listed on NYSE.

Hims Hers Health Inc (NYSE-HIMS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Hims Hers Health Inc is 13.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Hims Hers Health Inc is 91.0%. Free float helps investors understand how much of the share base is available for public trading.